BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37139166)

  • 1. CC16 as an Inflammatory Biomarker in Induced Sputum Reflects Chronic Obstructive Pulmonary Disease (COPD) Severity.
    Chen M; Xu K; He Y; Jin J; Mao R; Gao L; Zhang Y; Wang G; Gao P; Xie M; Liu C; Chen Z
    Int J Chron Obstruct Pulmon Dis; 2023; 18():705-717. PubMed ID: 37139166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular markers of type 2 airway inflammation are similar between eosinophilic severe asthma and eosinophilic chronic obstructive pulmonary disease.
    Fricker M; McDonald VM; Winter NA; Baines KJ; Wark PAB; Simpson JL; Gibson PG
    Allergy; 2021 Jul; 76(7):2079-2089. PubMed ID: 33470427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Inflammatory Markers in Induced Sputum in Stable Chronic Obstructive Pulmonary Disease Patients with Positive Bronchodilation Tests.
    Guo XX; Deng NS; Chen QH; Yu HY; Ding XH; Hu SP; Nie HX
    Curr Med Sci; 2019 Aug; 39(4):560-567. PubMed ID: 31346991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
    Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
    Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between expressions of myeloperoxidase and eosinophil cationic protein in sputum and clinical features of asthma-chronic obstructive pulmonary disease overlap].
    Yang H; Zhang Y; Zhang J; Pan J; Wang F; Luo X; Chen F
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1215-1221. PubMed ID: 30377121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sputum IL-25, IL-33 and TSLP, IL-23 and IL-36 in airway obstructive diseases. Reduced levels of IL-36 in eosinophilic phenotype.
    Moermans C; Damas K; Guiot J; Njock MS; Corhay JL; Henket M; Schleich F; Louis R
    Cytokine; 2021 Apr; 140():155421. PubMed ID: 33486314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between Blood and Induced Sputum Eosinophils, Bronchial Hyperresponsiveness and Reversibility of Airway Obstruction in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.
    Proboszcz M; Mycroft K; Paplinska-Goryca M; Górska K; Nejman-Gryz P; Jankowski P; Zak N; Krenke R
    COPD; 2019 Dec; 16(5-6):354-361. PubMed ID: 31631716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood cell for the differentiation of airway inflammatory phenotypes in COPD exacerbations.
    Gao J; Chen B; Wu S; Wu F
    BMC Pulm Med; 2020 Feb; 20(1):50. PubMed ID: 32093672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced Serum Concentration of CC16 Is Associated with Severity of Chronic Obstructive Pulmonary Disease and Contributes to the Diagnosis and Assessment of the Disease.
    Rong B; Fu T; Gao W; Li M; Rong C; Liu W; Liu H
    Int J Chron Obstruct Pulmon Dis; 2020; 15():461-470. PubMed ID: 32184583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Airway inflammation contributes to health status in COPD: a cross-sectional study.
    Snoeck-Stroband JB; Postma DS; Lapperre TS; Gosman MM; Thiadens HA; Kauffman HF; Sont JK; Jansen DF; Sterk PJ
    Respir Res; 2006 Nov; 7(1):140. PubMed ID: 17137518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD.
    Tworek D; Majewski S; Szewczyk K; Kiszałkiewicz J; Kurmanowska Z; Górski P; Brzeziańska-Lasota E; Kuna P; Antczak A
    Respir Res; 2018 Jun; 19(1):108. PubMed ID: 29859068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sputum ADAM8 expression is increased in severe asthma and COPD.
    Oreo KM; Gibson PG; Simpson JL; Wood LG; McDonald VM; Baines KJ
    Clin Exp Allergy; 2014 Mar; 44(3):342-52. PubMed ID: 24147597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: a feasibility randomized clinical trial.
    Greulich T; Hohlfeld JM; Neuser P; Lueer K; Klemmer A; Schade-Brittinger C; Harnisch S; Garn H; Renz H; Homburg U; Renz J; Kirsten A; Pedersen F; Müller M; Vogelmeier CF; Watz H
    Respir Res; 2018 Apr; 19(1):55. PubMed ID: 29615049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients.
    Pignatti P; Visca D; Cherubino F; Zampogna E; Lucini E; Saderi L; Sotgiu G; Spanevello A
    Respir Res; 2019 Jul; 20(1):145. PubMed ID: 31291952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls.
    Hou C; Zhao H; Liu L; Li W; Zhou X; Lv Y; Shen X; Liang Z; Cai S; Zou F
    Mol Med; 2011; 17(7-8):807-15. PubMed ID: 21380479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Airway inflammation and mannitol challenge test in COPD.
    de Nijs SB; Fens N; Lutter R; Dijkers E; Krouwels FH; Smids-Dierdorp BS; van Steenwijk RP; Sterk PJ
    Respir Res; 2011 Jan; 12(1):11. PubMed ID: 21241520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of serum CC16 levels with eosinophilic inflammation and respiratory dysfunction in severe asthma.
    Goudarzi H; Kimura H; Kimura H; Makita H; Takimoto-Sato M; Abe Y; Oguma A; Matsumoto M; Takei N; Matsumoto-Sasaki M; Shimizu K; Suzuki M; Shijubo N; Huang SK; Hizawa N; Nishimura M; Konno S
    Respir Med; 2023 Jan; 206():107089. PubMed ID: 36542961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.
    Bafadhel M; McKenna S; Terry S; Mistry V; Reid C; Haldar P; McCormick M; Haldar K; Kebadze T; Duvoix A; Lindblad K; Patel H; Rugman P; Dodson P; Jenkins M; Saunders M; Newbold P; Green RH; Venge P; Lomas DA; Barer MR; Johnston SL; Pavord ID; Brightling CE
    Am J Respir Crit Care Med; 2011 Sep; 184(6):662-71. PubMed ID: 21680942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective role for club cell secretory protein-16 (CC16) in the development of COPD.
    Laucho-Contreras ME; Polverino F; Gupta K; Taylor KL; Kelly E; Pinto-Plata V; Divo M; Ashfaq N; Petersen H; Stripp B; Pilon AL; Tesfaigzi Y; Celli BR; Owen CA
    Eur Respir J; 2015 Jun; 45(6):1544-56. PubMed ID: 25700379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships of serum CC16 levels with smoking status and lung function in COPD.
    Gribben KC; Poole JA; Nelson AJ; Farazi PA; Wichman CS; Heires AJ; Romberger DJ; LeVan TD
    Respir Res; 2022 Sep; 23(1):247. PubMed ID: 36114505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.